Welcome to Coulter Partners Global (English)

29 January 2025

Top hires for VC & PE portfolio companies Q4-2024

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Antibody-based therapies US
CEO Oncolytic viruses UK
CEO Oncology biotech Spain
Chief Financial Officer Nanotechnology diagnostics Switzerland
Chief Innovation Officer Connected medical devices France
Chief R&D Officer Gene-encoded drug discovery UK
Chief Commercial Officer Computational chemistry UK
Chief Operating Officer Outpatient services Switzerland
VP, Research & Preclinical Synthetic biology UK
VP, Global Head of Sales Omics platform US
VP, Marketing Men's health UK
Global Head of Regulatory Affairs Anticoagulant technologies UK
Head of Global Distribution Specialty pharma France
Program Director Pharma software solutions Belgium
Managing Partner Regulatory affairs consultancy US
Partner Healthcare strategic communications UK
Chair Cardiac devices Israel
Board Director Specialty ingredients UK

Newly opened projects include:

Function Focus area Location
CEO Exosome technologies Italy
Chief Scientific Officer tRNA platform US
Chief Business Officer 3D genome technologies UK
Chief Scientific Officer Protein degraders Italy
Chief Development Officer T-cell technologies UK
SVP, Clinical Operations Cell therapies US
VP, Country General Manager Contract Research Organization Japan
VP, Pharma Partnerships Digital diagnostics UK
VP, Head of Early Discovery Computational drug discovery Denmark
Global Head Toxicology Services Laboratory & consulting services Germany
Head of Sales International Medical lasers Germany
Head of Regulatory Small molecule inhibitors US
Marketing & Business Development Lead Biological & chemical sensors France
Country General Manager Patient services UK
Board Director Immunotherapies Belgium
Director of Venture Creation University commercialization arm UK

Related

A new version of Coulter Partners is available.